
For many years dementia was considered an inevitable consequence of ageing, with little that individuals could do to influence their risk. Contemporary research, however, paints a far more optimistic picture. While no intervention can guarantee that dementia will be prevented, accumulating evidence suggests that many cases may be delayed—or potentially avoided altogether—through lifestyle modification and management of health conditions.
The most influential publication in this field, the 2024 Lancet Commission on Dementia Prevention, Intervention and Care, concluded that approximately 45% of dementia cases may be attributable to modifiable risk factors throughout life (Livingston et al., 2024). This does not imply that nearly half of all dementia cases can be completely prevented, but rather that addressing these risk factors could substantially reduce population-wide incidence.
Understanding these findings requires an appreciation of how dementia develops.
Dementia is not caused by a single process.
Alzheimer's disease, vascular dementia, Lewy body dementia, and frontotemporal dementia all involve different pathological mechanisms, although considerable overlap exists. Alzheimer's disease, the most common form, is characterised by the accumulation of amyloid-β plaques and tau neurofibrillary tangles, chronic neuroinflammation, synaptic dysfunction, and progressive neuronal loss.
Vascular dementia results primarily from impaired blood flow to the brain.
Note: Many individuals experience mixed pathology involving both Alzheimer's disease and cerebrovascular disease.
Because multiple biological pathways contribute to dementia, prevention strategies must target several interconnected systems rather than one specific cause.
One of the most important concepts in dementia prevention is cognitive reserve.
Cognitive reserve refers to the brain's ability to continue functioning despite age-related changes or pathological damage. Individuals with greater cognitive reserve appear able to tolerate more Alzheimer's pathology before clinical symptoms become apparent.
This theory helps explain why two individuals with similar levels of amyloid deposition may experience vastly different cognitive outcomes. One person may develop significant memory impairment, while another remains cognitively normal for years.
Education, intellectually stimulating occupations, bilingualism, lifelong learning, and regular cognitive activity all appear to increase cognitive reserve. Rather than preventing pathology itself, these experiences may improve the efficiency and flexibility of neural networks, allowing the brain to compensate for damage more effectively.
This distinction is important because many lifestyle interventions may delay the onset of dementia symptoms even if they do not completely prevent the underlying disease processes.
Among all modifiable risk factors, cardiovascular health has perhaps the strongest and most consistent evidence.
The brain accounts for only around 2% of total body weight but consumes approximately 20% of the body's oxygen supply. Consequently, even modest reductions in cerebral blood flow can impair neuronal function over many years.
Hypertension, diabetes, obesity, hypercholesterolaemia, and smoking all damage blood vessels through inflammation, oxidative stress, and endothelial dysfunction. These processes reduce cerebral perfusion and increase the likelihood of both overt strokes and silent microvascular injury.
Modern neuroimaging has shown that many older adults accumulate numerous tiny infarcts without ever experiencing obvious stroke symptoms. Collectively, these lesions contribute substantially to cognitive decline.
Moreover, vascular disease appears to accelerate Alzheimer's pathology. Reduced blood flow impairs the clearance of amyloid-β proteins through the brain's glymphatic and vascular drainage systems. Chronic hypoperfusion also promotes inflammation, oxidative damage, and blood–brain barrier dysfunction, potentially creating conditions that favour neurodegeneration.
Thus, cardiovascular disease and Alzheimer's disease should not be viewed as independent disorders but rather as interacting processes.
Longitudinal studies consistently demonstrate that hypertension during midlife significantly increases dementia risk decades later.
Persistently elevated blood pressure damages small cerebral arteries, leading to white matter lesions, lacunar infarcts, and reduced cerebral blood flow. Over time these structural changes impair executive function, attention, and memory.
The SPRINT-MIND trial provided particularly compelling evidence that intensive blood pressure control reduced the incidence of mild cognitive impairment—a recognised precursor to dementia. Although reductions in diagnosed dementia itself did not reach statistical significance during the study period, researchers concluded that longer follow-up would likely demonstrate meaningful benefits.
Importantly, treatment appears most beneficial during middle age rather than after significant neurological damage has already occurred.
Type 2 diabetes approximately doubles the risk of developing dementia.
Several mechanisms contribute to this increased risk.
Chronic hyperglycaemia damages blood vessels supplying the brain, while insulin resistance may interfere directly with neuronal function. Some researchers have even described Alzheimer's disease as "type 3 diabetes," although this terminology remains controversial because Alzheimer's pathology is considerably more complex than impaired insulin signalling alone.
Inflammation, oxidative stress, mitochondrial dysfunction, and abnormal glucose metabolism all interact to accelerate neurodegeneration.
Large observational studies indicate that individuals who maintain good glycaemic control experience slower rates of cognitive decline than those with poorly controlled diabetes.
Nevertheless, intensive glucose lowering has not consistently demonstrated dramatic reductions in dementia incidence, illustrating an important principle throughout dementia prevention research: improving risk factors often produces modest cumulative benefits rather than dramatic individual effects.
Elevated cholesterol during midlife contributes to atherosclerosis, reducing cerebral blood flow and increasing stroke risk.
Obesity similarly promotes systemic inflammation, hypertension, diabetes, and metabolic syndrome—all recognised contributors to cognitive decline.
Interestingly, obesity appears most harmful during middle adulthood. Weight loss occurring immediately before dementia diagnosis is common and probably reflects early disease processes rather than protection from obesity itself. This phenomenon illustrates one of the challenges in dementia research: reverse causation can complicate interpretation of observational studies.
Current evidence therefore emphasises maintaining a healthy body weight throughout adulthood rather than attempting weight loss late in life solely for dementia prevention.
Although cardiovascular risk reduction represents one of the strongest areas of dementia prevention research, several limitations deserve consideration.
Much evidence derives from observational cohort studies rather than randomised controlled trials. Individuals who exercise, eat well, and maintain healthy blood pressure often differ from others in many additional ways, including education, income, healthcare access, and health literacy. These factors may independently reduce dementia risk.
Randomised intervention trials are difficult because dementia develops over several decades. Conducting studies that follow participants for thirty years is logistically challenging and prohibitively expensive.
Nevertheless, when observational findings are combined with mechanistic laboratory studies, neuroimaging research, and shorter-term intervention trials, the overall evidence strongly supports cardiovascular health as a cornerstone of dementia prevention.
Importantly, even if cardiovascular interventions produce only modest reductions in dementia incidence, they simultaneously reduce stroke, heart disease, kidney disease, and overall mortality. Consequently, these interventions remain highly valuable from both individual and public health perspectives.
Protecting cardiovascular health represents only one component of dementia prevention. Equally important are physical exercise, nutrition, lifelong learning, sleep, hearing preservation, social engagement, and mental wellbeing. These factors often interact, creating cumulative benefits that exceed the effect of any single intervention alone.
The next article examines the evidence for exercise, nutrition, and cognitive stimulation, exploring why these lifestyle factors may strengthen brain resilience and delay cognitive decline.
Barnes, D. E., & Yaffe, K. (2011). The projected effect of risk factor reduction on Alzheimer's disease prevalence. The Lancet Neurology, 10(9), 819–828.
Rajeev V, Chai YL, Poh L, Selvaraji S, Fann DY, Jo DG, De Silva TM, Drummond GR, Sobey CG, Arumugam TV, Chen CP, Lai MKP. Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment. Acta Neuropathol Commun. 2023 Jun 12;11(1):93. doi: 10.1186/s40478-023-01590-1. PMID: 37309012; PMCID: PMC10259064.
World Health Organization. (2019). Risk reduction of cognitive decline and dementia: WHO guidelines. Geneva: WHO.
Williamson, J. D., Pajewski, N. M., Auchus, A. P., et al. (2019). Effect of intensive vs standard blood pressure control on probable dementia: A randomized clinical trial. JAMA, 321(6), 553–561.
Continue your Dementia-Prevention strategy with
Part 2 – Exercise, Diet, Sleep and Brain Plasticity: neuroplasticity, BDNF, Mediterranean and MIND diets, glymphatic clearance during sleep, inflammation, oxidative stress, and a critical appraisal of the evidence.
Part 3 – Lifelong Learning, Hearing, Vision, Social Connection and Mental Health: cognitive reserve, sensory impairment, depression, loneliness, air pollution, head injury, emerging risk factors, and future directions (including biomarkers, genetics, and precision prevention).
